Virulence determinants in vancomycin-resistant Enterococcus faecium vanB: clonal distribution, prevalence and significance of esp and hyl in Australian patients with haematological disorders

Journal of Hospital Infection

Volumn 68, Issue 2, 2008, Pages 137-144

  Worth, L J ^a,b   Slavin, M A ^a,b   Vankerckhoven, V ^c   Goossens, H ^c   Grabsch, E A ^d   Thursky, K A ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d AUSTIN HEALTH   (Australia)

Author keywords

Vancomycin resistant Enterococcus faecium; Virulence factors

Indexed keywords

BACTERIAL PROTEIN; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; PROTEIN ASA1; PROTEIN CYLA; PROTEIN ESP; PROTEIN GEL E; PROTEIN HYL; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN; VIRULENCE FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLONAL VARIATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EWING SARCOMA; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; MALE; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; AUSTRALIA; BACTERIAL PROTEINS; CLONE CELLS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROTO-ONCOGENE PROTEINS PP60(C-SRC); VANCOMYCIN RESISTANCE; VIRULENCE;

EID: 39049121232     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.10.017     Document Type: Article

References (39)

1. Noskin G.A., Cooper I., and Peterson L.R. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization. Arch Intern Med 155 (1995) 1445-1447
2. Suntharam N., Lankford M.G., Trick W.E., Peterson L.R., and Noskin G.A. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 43 (2002) 183-188
3. Avery R., Kalaycio M., Pohlman B., et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transpl 35 (2005) 497-499
4. Guzman C.A., Pruzzo C., LiPira G., and Calegari L. Role of adherence in pathogenesis of Enterococcus faecalis urinary tract infection and endocarditis. Infect Immun 57 (1989) 1834-1838
5. Kreft B., Marre R., Schramm U., and Wirth R. Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun 60 (1992) 25-30
6. Gutschik E., Moller S., and Christensen N. Experimental endocarditis in rabbits. 3. Significance of the proteolytic capacity of the infecting strains of Streptococcus faecalis. Acta Pathol Microbiol Scand [B] 87 (1979) 353-362
7. Chow J.W., Thal L.A., Perri M.B., et al. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother 37 (1993) 2474-2477
8. Rice L.B., Carias L., Rudin S., et al. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187 (2003) 508-512
9. Tendolkar P.M., Baghdayan A.S., Gilmore M.S., and Shankar N. Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun 72 (2004) 6032-6039
10. Waar K., Muscholl-Silberhorn A.B., Willems R.J., Slooff M.J., Harmsen H.J., and Degener J.E. Genogrouping and incidence of virulence factors of Enterococcus faecalis in liver transplant patients differ from blood culture and fecal isolates. J Infect Dis 185 (2002) 1121-1127
11. Eaton T.J., and Gasson M.J. A variant enterococcal surface protein Esp(fm) in Enterococcus faecium; distribution among food, commensal, medical, and environmental isolates. FEMS Microbiol Lett 216 (2002) 269-275
12. Shankar V., Baghdayan A.S., Huycke M.M., Lindahl G., and Gilmore M.S. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 67 (1999) 193-200
13. Coque T.M., Willems R.J., Fortun J., et al. Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance?. Antimicrob Agents Chemother 49 (2005) 2693-2700
14. Dworniczek E., Wojciech L., Sobieszczanska B., and Seniuk A. Virulence of Enterococcus isolates collected in Lower Silesia (Poland). Scand J Infect Dis 37 (2005) 630-636
15. Mannu L., Paba A., Daga E., et al. Comparison of the incidence of virulence determinants and antibiotic resistance between Enterococcus faecium strains of dairy, animal and clinical origin. Int J Food Microbiol 88 (2003) 291-304
16. Sedgley C.M., Molander A., Flannagan S.E., et al. Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp. Oral Microbiol Immunol 20 (2005) 10-19
17. Stampone L., Del Grosso M., Boccia D., and Pantosti A. Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy. J Clin Microbiol 43 (2005) 1575-1580
18. Vankerckhoven V., Van Autgaerden T., Vael C., et al. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 42 (2004) 4473-4479
19. Willems R.J., Homan W., Top J., et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357 (2001) 853-855
20. Woodford N., Soltani M., and Hardy K.J. Frequency of esp in Enterococcus faecium isolates. Lancet 358 (2001) 584
21. Eliopoulos G.M., Wennersten C.B., Gold H.S., et al. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob Agents Chemother 42 (1998) 1088-1092
22. Goossens H., Jabes D., Rossi R., Lammens C., Privitera G., and Courvalin P. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother 51 Suppl. 3 (2003) iii5-iii12
23. Bell J., Turnidge J., Coombs G., and O'Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell 22 (1998) 249-252
24. Christiansen K.J., Tibbett P.A., Beresford W., et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 25 (2004) 384-390
25. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
26. Worth L.J., Thursky K.A., Seymour J.F., and Slavin M.A. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 79 (2007) 226-233
27. Teixeira L.M., and Facklam R.R. Enterococcus. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.F. (Eds). Manual of clinical microbiology. 8th edn (2003), ASM Press, Washington DC 422-428
28. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement (2005), Clinical and Laboratory Standards Institute, Wayne, PA
29. Bell J.M., Paton J.C., and Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 36 (1998) 2187-2190
30. Miranda A.G., Singh K.V., and Murray B.E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 29 (1991) 2752-2757
31. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
32. Papanicolaou G.A., Meyers B.R., Meyers J., et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 23 (1996) 760-766
33. Vergis E.N., Shankar N., Chow J.W., et al. Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin Infect Dis 35 (2002) 570-575
34. Grayson M.L., Grabsch E.A., Johnson P.D., et al. Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust 171 (1999) 133-136
35. Dupre I., Zanetti S., Schito A.M., Fadda G., and Sechi L.A. Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy). J Med Microbiol 52 (2003) 491-498
36. Willems R.J., Top J., van Santen M., et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11 (2005) 821-828
37. Deplano A., Denis O., Nonhoff C., et al. Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control. J Antimicrob Chemother 60 (2007) 849-854
38. Kuehnert M.J., Jernigan J.A., Pullen A.L., Rimland D., and Jarvis W.R. Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol 20 (1999) 660-663
39. Pearman J.W. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. J Hosp Infect 63 (2006) 14-26